Gavi, the Vaccine Alliance
Acronym: Gavi
General Information
Identification Code: 078294941111-90
Website: [object Object]
Entity Form: International institution with privileges and immunities in Switzerland; Non-profit foundation
Registration Category: Other organisations, public or mixed entities
Registration Date: 1/27/2021
Last Update: 2/12/2024
EP Accredited Number: 0
Mission & Interests
Goals: Gavi’s mission is: “Saving children’s lives and protecting people’s health by increasing equitable use of vaccines in lower-income countries."
The Gavi Alliance promotes health by: (i) providing vaccines and the means to deliver such vaccines to people in the poorest countries; (ii) facilitating the research and development of vaccines of primary interest to the developing world; and (iii) providing support in connection with achieving the foregoing purposes by helping to strengthen health care systems and civil societies supporting such purposes in the developing world.
Gavi co-led COVAX, the vaccines pillar of the Access to COVID-19 Tools (ACT) Accelerator.
Interests Represented: Promotes their own interests or the collective interests of their members
Interests:
- International co-operation and development
- Public health
Levels of Interest:
- global
Activities
Main EU Legislative Proposals: European Consensus on Development
EU Strategy on Africa
EU Global Health Strategy
Global Gateway
MAV+ Initiative
Global COVID-19 vaccine response
Communication Activities: Global Gateway Summit
Global Health Policy Forum
Regular calls with DG INTPA (donor calls)
Inter-institutional or Unofficial Groupings: N/A
Head Office
Address: Gavi, the Vaccine AllianceChemin du Pommier, 40
Post Code: 1218
City: Grand-Saconnex
Country: SWITZERLAND
Phone: [object Object]
EU Office
Address: Gavi, the Vaccine AllianceChemin du Pommier, 40
Post Code: 1218
City: Grand-Saconnex
Country: SWITZERLAND
Phone: [object Object]
Financial Data
New Organisation: false
Closed Year: [object Object]
Current Year: [object Object]
Complementary Information: Contributions reflected in the closed financial year only include contributions that were recognized in that year following the expense verification audit (and not cash received). Financial statements for the year 2023 are not yet finalized as of February 12, 2024.
Membership Information
Members10 Percent: 0
Members25 Percent: 1
Members50 Percent: 0
Members75 Percent: 1
Members: 2
Members F T E: 1
Structure
Structure Type: Structure
Is Member Of: The Gavi Board is responsible for strategic direction and policy-making, oversees the operations of the Vaccine Alliance and monitors programme implementation. With membership drawn from a range of partner organisations, as well as experts from the private sector, the Gavi Board provides a forum for balanced strategic decision making, innovation and partner collaboration. Gavi partners are represented through 18 seats on the Board with nine seats reserved for independent or unaffiliated individuals.
Committees support the development of key policies, oversee specific activities and are comprised of Board members, alternates, and in some instances delegates with expertise in critical areas.
The Board is the supreme governing body of Gavi, the Vaccine Alliance. Certain functions are reserved to the Board, including the setting of policies and strategies for Gavi, and amending its by-laws and other internal guidelines and procedures necessary for the administration and management of the Vaccine Alliance.
The Board delegates certain activities and areas of work to five standing Board committees and one Advisory committee, staffed by Board members, alternates, and in certain instances independent experts or partner representatives. The committees include:
• Programme and Policy Committee;
• Governance Committee;
• Investment Committee;
• Audit & Finance Committee; and
• Evaluation Advisory Committee.
Organisation Members: The Board is comprised of 18 “representative” seats, 9 seats for independent or “unaffiliated” individuals and one seat for Gavi's CEO. The Board’s representative seats ensure that institutions and constituencies can provide formal input into the development of all Gavi’s policies and the management of its operations.
UNICEF, WHO, the World Bank and the Bill & Melinda Gates Foundation hold permanent seats on the Board. Constituency representatives serve on a time-limited basis. Board members include representation from donor governments, implementing country governments, civil society organisations and the vaccine industry.
Independent Board members are private individuals with no professional connection to Gavi’s work. They bring independent and balanced scrutiny to all of the Board’s deliberations. These individuals also provide expertise in a number of critical areas such as investment, auditing and fundraising.